Skip to content

Clinical trials

Expanded access trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Country / region: Poland Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available10
Approved for marketing8
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eisai Inc.3
Novartis Pharmaceuticals3
Bayer2
Pfizer2
AstraZeneca1
BioMarin Pharmaceutical1
Eli Lilly and Company1
Gilead Sciences1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Novartis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Lennox Gastaut Syndrome2
Acquired Immunodeficiency Syndrome1
Brain Diseases1
COVID-191
Carcinoma, Medullary1
Carcinoma, Renal Cell1
Colonic Neoplasms1
Colorectal Neoplasms1

Trials

Showing 51 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.